Schrodinger (SDGR) closed at $22.60 on October 16, 2026, down 11.3% from the previous close, on volume of 2,598,092 shares (30-day average 2,569,428).
Data as of October 16, 2026.
16-Oct-2026
Market Chameleon (Thu, 15-Oct 4:05 AM ET)
Schrdinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
Business Wire (Wed, 14-Oct 11:05 AM ET)
Schrödinger Highlights 2,243-Share Inducement RSU Grants as SDGR Trades Higher Midday
Market Chameleon (Thu, 17-Sep 7:33 AM ET)
Schr6dinger Highlights 2,243-Share Inducement RSU Grants for New Hires Under Nasdaq Rule 5635(c)(4)
Market Chameleon (Thu, 17-Sep 7:01 AM ET)
Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Thu, 17-Sep 8:30 AM ET)
Business Wire (Wed, 9-Sep 7:00 AM ET)
Schrdinger to Present at Morgan Stanley Global Healthcare Conference
Business Wire (Tue, 1-Sep 8:30 AM ET)
AI Found an Influenza Target That Survives Viral Mutation
Globe Newswire (Mon, 10-Aug 9:10 AM ET)
Schrdinger Reports Second Quarter 2026 Financial Results
Business Wire (Wed, 5-Aug 4:05 PM ET)
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Schrodinger trades on the NASDAQ stock market under the symbol SDGR.
As of October 16, 2026, SDGR stock price declined to $22.60 with 2,598,092 million shares trading.
SDGR has a beta of 2.17, meaning it tends to be more sensitive to market movements. SDGR has a correlation of 0.13 to the broad based SPY ETF.
SDGR has a market cap of $1.69 billion. This is considered a Small Cap stock.
Last quarter Schrodinger reported $59 million in Revenue and $.08 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.68.
In the last 3 years, SDGR traded as high as $38.00 and as low as $10.95.
The top ETF exchange traded funds that SDGR belongs to (by Net Assets): ARKG, IJR, VTI, VB, IWM.
SDGR has underperformed the market in the last year with a price return of +11.3% while the SPY ETF gained +16.7%. However, in the short term, SDGR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +44.9% vs +1.9% return in SPY. But in the last 2 weeks, SDGR shares have been beat by the market, returning -25.4% compared to an SPY return of -0.8%.
SDGR support price is $24.35 and resistance is $26.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SDGR shares will trade within this expected range on the day.
